Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95). M-IV's high
Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95).
M-IV's high transmission cellular grid system (HTC) improvescontrast in screen-film mammography at an equal or lower radiationdose than conventional systems, according to Hal Kirshner, presidentof Lorad and ThermoTrex Medical. It should prove particularlyuseful for imaging patients with dense breasts, Kirshner said.HTC will be available as an option on M-IV units.
Lorad will also reveal its latest work in full-view digital mammography.The company will show patient images acquired with a system beingused by Dr. Laurie Fajardo at the University of Virginia.
In addition, the company has adapted its StereoLoc prone digitalbreast biopsy technology for its upright mammography systems.Lorad will also display a line of radiographic equipment beingdeveloped for the firm by Bennett X-Ray, its new sister company.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.